The Discounted Cash Flow (DCF) valuation of Sarepta Therapeutics Inc (SRPT) is 46.37 USD. With the latest stock price at 36.18 USD, the upside of Sarepta Therapeutics Inc based on DCF is 28.2%.
Based on the latest price of 36.18 USD and our DCF valuation, Sarepta Therapeutics Inc (SRPT) is a buy. buying SRPT stocks now will result in a potential gain of 28.2%.
| Range | Selected | |
| WACC / Discount Rate | 7.9% - 10.6% | 9.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 30.15 - 87.98 | 46.37 |
| Upside | -16.7% - 143.2% | 28.2% |